{
      "StudyFieldsResponse": {
            "APIVrs": "1.01.05",
            "DataVrs": "2022:10:06 23:25:58.836",
            "Expression": "mesenchymal allo-hMSCs",
            "NStudiesAvail": 430108,
            "NStudiesFound": 14,
            "MinRank": 1,
            "MaxRank": 1000,
            "NStudiesReturned": 14,
            "FieldList": [
                  "MaximumAge",
                  "MinimumAge",
                  "NCTId",
                  "NCTIdAlias",
                  "OfficialTitle",
                  "OrgClass",
                  "OrgFullName",
                  "OrgStudyId",
                  "OrgStudyIdDomain",
                  "OrgStudyIdLink",
                  "OrgStudyIdType",
                  "OtherEventAssessmentType",
                  "OtherEventNotes",
                  "OtherEventOrganSystem",
                  "OtherEventSourceVocabulary"
            ],
            "StudyFields": [
                  {
                        "Rank": 1,
                        "MaximumAge": [
                              "80 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT05522569"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Expanded Access Multi-Patient Experimental Treatment Involving Allogeneic Human Mesenchymal Stem Cells (Allo-hMSCs) in Subjects With Acute Ischemic Stroke (EXPAND)"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "University of Miami"
                        ],
                        "OrgStudyId": [
                              "20201338"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 2,
                        "MaximumAge": [
                              "75 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02675556"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase I, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Potential Efficacy of Allogeneic Human Mesenchymal Stem Cell Infusion Versus Placebo in Patients With Treatment Resistant Depression."
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "University of Miami"
                        ],
                        "OrgStudyId": [
                              "20140917"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 3,
                        "MaximumAge": [
                              "75 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03265808"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase I/II, Prospective, Randomized, Double-Blind, PlAcebo-ControLled Trial to EvAluate the Potential Efficacy of Allogeneic HUman Mesenchymal Stem Cell InfusioN Versus Placebo in Subjects With Alcohol Use Disorder and Major DepreSsion."
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "University of Miami"
                        ],
                        "OrgStudyId": [
                              "20170674"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 4,
                        "MaximumAge": [
                              "30 Days"
                        ],
                        "MinimumAge": [],
                        "NCTId": [
                              "NCT02398604"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Allogeneic Human MEsenchymal Stem Cell (hMSC) Injection in Patients With Hypoplastic Left Heart Syndrome: An Open Label Pilot Study."
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Longeveron Inc."
                        ],
                        "OrgStudyId": [
                              "20140718"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 5,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02677350"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase I, Pilot Trial to Evaluate the Safety and Efficacy of Injection of Allogeneic Mesenchymal Bone-Marrow Derived Human Stem Cells in Patients With Fistulizing Crohn's Disease."
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "University of Miami"
                        ],
                        "OrgStudyId": [
                              "20150965"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 6,
                        "MaximumAge": [
                              "90 Years"
                        ],
                        "MinimumAge": [
                              "21 Years"
                        ],
                        "NCTId": [
                              "NCT01087996"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase I/II, Randomized Pilot Study of the Comparative Safety and Efficacy of Transendocardial Injection of Autologous Mesenchymal Stem Cells Versus Allogeneic Mesenchymal Stem Cells in Patients With Chronic Ischemic Left Ventricular Dysfunction Secondary to Myocardial Infarction"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "University of Miami"
                        ],
                        "OrgStudyId": [
                              "20090352"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment"
                        ],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [
                              "Cardiac disorders",
                              "Eye disorders",
                              "Gastrointestinal disorders",
                              "General disorders",
                              "Infections and infestations",
                              "Injury, poisoning and procedural complications",
                              "Metabolism and nutrition disorders",
                              "Musculoskeletal and connective tissue disorders",
                              "Nervous system disorders",
                              "Renal and urinary disorders",
                              "Respiratory, thoracic and mediastinal disorders",
                              "Skin and subcutaneous tissue disorders",
                              "Vascular disorders"
                        ],
                        "OtherEventSourceVocabulary": [
                              "MedDRA (10.0)",
                              "MedDRA (10.0)",
                              "MedDRA (10.0)",
                              "MedDRA (10.0)",
                              "MedDRA (10.0)",
                              "MedDRA (10.0)",
                              "MedDRA (10.0)",
                              "MedDRA (10.0)",
                              "MedDRA (10.0)",
                              "MedDRA (10.0)",
                              "MedDRA (10.0)",
                              "MedDRA (10.0)",
                              "MedDRA (10.0)"
                        ]
                  },
                  {
                        "Rank": 7,
                        "MaximumAge": [
                              "95 Years"
                        ],
                        "MinimumAge": [
                              "60 Years"
                        ],
                        "NCTId": [
                              "NCT02065245"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase I/II, Randomized, Blinded and Placebo-controlled Trial to Evaluate the Safety and Potential Efficacy of Allogeneic Human Mesenchymal Stem Cell Infusion in Patients With Aging Frailty"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Longeveron Inc."
                        ],
                        "OrgStudyId": [
                              "20130646"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 8,
                        "MaximumAge": [
                              "75 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03487731"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase I/II, Randomized, Blinded and Placebo-controlled Trial to EValuate the Safety and Potential Efficacy of Allogeneic Human Mesenchymal Stem Cell Injection in PAtieNts With FaceTogenic Back Pain"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "University of Miami"
                        ],
                        "OrgStudyId": [
                              "20180018"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 9,
                        "MaximumAge": [
                              "45 Years"
                        ],
                        "MinimumAge": [
                              "20 Years"
                        ],
                        "NCTId": [
                              "NCT03058068"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase I, Randomized and Placebo-controlled Trial to Evaluate the Safety, Tolerability, and Potential Efficacy of Allogeneic Human MesenchymAl Stem Cells Infusion in Patients With Cystic Fibrosis - HAPI"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "University of Miami"
                        ],
                        "OrgStudyId": [
                              "20160140"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 10,
                        "MaximumAge": [
                              "90 Years"
                        ],
                        "MinimumAge": [
                              "21 Years"
                        ],
                        "NCTId": [
                              "NCT02886884"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase I/II, Randomized, Double Blind, Pilot Trial to Evaluate the Safety and Efficacy of Allogeneic Mesenchymal Human Stem Cells Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "University of Miami"
                        ],
                        "OrgStudyId": [
                              "20160686"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment"
                        ],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [
                              "Blood and lymphatic system disorders",
                              "Blood and lymphatic system disorders",
                              "Cardiac disorders",
                              "Cardiac disorders",
                              "Eye disorders",
                              "Gastrointestinal disorders",
                              "Gastrointestinal disorders",
                              "Immune system disorders",
                              "Immune system disorders",
                              "Infections and infestations",
                              "Infections and infestations",
                              "Infections and infestations",
                              "Infections and infestations",
                              "Injury, poisoning and procedural complications",
                              "Injury, poisoning and procedural complications",
                              "Metabolism and nutrition disorders",
                              "Metabolism and nutrition disorders",
                              "Metabolism and nutrition disorders",
                              "Metabolism and nutrition disorders",
                              "Musculoskeletal and connective tissue disorders",
                              "Musculoskeletal and connective tissue disorders",
                              "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                              "Renal and urinary disorders",
                              "Renal and urinary disorders",
                              "Renal and urinary disorders",
                              "Renal and urinary disorders",
                              "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                              "Respiratory, thoracic and mediastinal disorders",
                              "Skin and subcutaneous tissue disorders",
                              "Skin and subcutaneous tissue disorders",
                              "Skin and subcutaneous tissue disorders",
                              "Vascular disorders"
                        ],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 11,
                        "MaximumAge": [
                              "90 Years"
                        ],
                        "MinimumAge": [
                              "40 Years"
                        ],
                        "NCTId": [
                              "NCT02013700"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase I, Randomized, Blinded and Placebo-controlled Trial to Evaluate the Safety, Tolerability, and Potential Efficacy of Allogeneic Human Mesenchymal Stem Cell Infusion in Patients With Idiopathic Pulmonary Fibrosis"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "University of Miami"
                        ],
                        "OrgStudyId": [
                              "20120946"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 12,
                        "MaximumAge": [
                              "90 Years"
                        ],
                        "MinimumAge": [
                              "21 Years"
                        ],
                        "NCTId": [
                              "NCT02013674"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase II, Randomized, Blinded, Study of the Safety and Efficacy of Transendocardial Injection of Allogeneic Human Mesenchymal Stem Cells (hMSCs) (20 Million or 100 Million Total MSCs) in Patients With Chronic Ischemic Left Ventricular Dysfunction Secondary to Myocardial Infarction."
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "University of Miami"
                        ],
                        "OrgStudyId": [
                              "20120660"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment"
                        ],
                        "OtherEventNotes": [
                              "Adverse events within 12 months of injection",
                              "Adverse events within 12 months of injection",
                              "Adverse events within 12 months of injection",
                              "Adverse events within 12 months of injection",
                              "Adverse events within 12 months of injection",
                              "Adverse events within 12 months of injection",
                              "Adverse events within 12 months of injection",
                              "Adverse events within 12 months of injection",
                              "Adverse events within 12 months of injection",
                              "Adverse events within 12 months of injection",
                              "Adverse events within 12 months of injection",
                              "Adverse events within 12 months of injection",
                              "Adverse events within 12 months of injection",
                              "Adverse events within 12 months of injection",
                              "Adverse events within 12 months of injection",
                              "Adverse events within 12 months of injection",
                              "Adverse events within 12 months of injection",
                              "Adverse events within 12 months of injection",
                              "Adverse events within 12 months of injection",
                              "Adverse events within 12 months of injection",
                              "Adverse events within 12 months of injection",
                              "Adverse events within 12 months of injection",
                              "Adverse events within 12 months of injection",
                              "Adverse events within 12 months of injection",
                              "Adverse events within 12 months of injection",
                              "Adverse events within 12 months of injection",
                              "Adverse events within 12 months of injection",
                              "Adverse events within 12 months of injection",
                              "Adverse events within 12 months of injection",
                              "Adverse events within 12 months of injection",
                              "Adverse events within 12 months of injection",
                              "Adverse events within 12 months of injection",
                              "Adverse events within 12 months of injection",
                              "Adverse events within 12 months of injection",
                              "Adverse events within 12 months of injection",
                              "Adverse events within 12 months of injection",
                              "Adverse events within 12 months of injection",
                              "Adverse events within 12 months of injection",
                              "Adverse events within 12 months of injection",
                              "Adverse events within 12 months of injection",
                              "Adverse events within 12 months of injection",
                              "Adverse events within 12 months of injection",
                              "Adverse events within 12 months of injection",
                              "Adverse events within 12 months of injection"
                        ],
                        "OtherEventOrganSystem": [
                              "Cardiac disorders",
                              "Cardiac disorders",
                              "Cardiac disorders",
                              "Cardiac disorders",
                              "Cardiac disorders",
                              "Ear and labyrinth disorders",
                              "Eye disorders",
                              "Eye disorders",
                              "Eye disorders",
                              "Gastrointestinal disorders",
                              "Gastrointestinal disorders",
                              "General disorders",
                              "General disorders",
                              "General disorders",
                              "Infections and infestations",
                              "Infections and infestations",
                              "Infections and infestations",
                              "Injury, poisoning and procedural complications",
                              "Investigations",
                              "Metabolism and nutrition disorders",
                              "Metabolism and nutrition disorders",
                              "Musculoskeletal and connective tissue disorders",
                              "Musculoskeletal and connective tissue disorders",
                              "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                              "Nervous system disorders",
                              "Renal and urinary disorders",
                              "Renal and urinary disorders",
                              "Reproductive system and breast disorders",
                              "Respiratory, thoracic and mediastinal disorders",
                              "Respiratory, thoracic and mediastinal disorders",
                              "Respiratory, thoracic and mediastinal disorders",
                              "Respiratory, thoracic and mediastinal disorders",
                              "Skin and subcutaneous tissue disorders",
                              "Skin and subcutaneous tissue disorders",
                              "Vascular disorders",
                              "Vascular disorders",
                              "Vascular disorders",
                              "General disorders",
                              "Infections and infestations",
                              "Surgical and medical procedures",
                              "Surgical and medical procedures",
                              "Surgical and medical procedures",
                              "Reproductive system and breast disorders",
                              "Musculoskeletal and connective tissue disorders"
                        ],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 13,
                        "MaximumAge": [
                              "95 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT01392625"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase I/II, Randomized Pilot Study of the Comparative Safety and Efficacy of Transendocardial Injection of Autologous Mesenchymal Stem Cells Versus Allogeneic Mesenchymal Stem Cells in Patients With Non-ischemic Dilated Cardiomyopathy."
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "University of Miami"
                        ],
                        "OrgStudyId": [
                              "20100968"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment"
                        ],
                        "OtherEventNotes": [
                              "Treatment Emergent Adverse event at one-month",
                              "Treatment Emergent AE at 1-month",
                              "Treatment emergent adverse event at 1 month",
                              "Treatment emergent adverse event at 1 month",
                              "Treatment emergent adverse event at 1 month",
                              "Treatment emergent adverse event at 1 month",
                              "Treatment emergent adverse event at 1 month",
                              "Treatment emergent adverse event at 1 month",
                              "Treatment emergent adverse event at 1 month",
                              "Treatment emergent adverse event at 1 month",
                              "Treatment emergent adverse event at 1 month",
                              "Treatment emergent adverse event at 1 month",
                              "Treatment emergent adverse event at 1 month",
                              "Treatment emergent adverse event at 1 month",
                              "Treatment emergent adverse event at 1 month"
                        ],
                        "OtherEventOrganSystem": [
                              "Blood and lymphatic system disorders",
                              "Cardiac disorders",
                              "Cardiac disorders",
                              "General disorders",
                              "General disorders",
                              "Infections and infestations",
                              "Infections and infestations",
                              "Investigations",
                              "Investigations",
                              "Nervous system disorders",
                              "Nervous system disorders",
                              "Product Issues",
                              "Respiratory, thoracic and mediastinal disorders",
                              "Respiratory, thoracic and mediastinal disorders",
                              "Surgical and medical procedures"
                        ],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 14,
                        "MaximumAge": [
                              "80 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04476901"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase IIB Randomized, Placebo-Controlled, Multicenter Study of the Comparative Efficacy and Safety of Transendocardial Injection of Allogeneic-MSC Versus Placebo in Patients With Non- Ischemic Dilated Cardiomyopathy"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "University of Miami"
                        ],
                        "OrgStudyId": [
                              "20200566"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  }
            ]
      }
}